Clinical outcome and prognosis of patients with acute myeloid leukemia submitted to chemotherapy with 5 years of follow-up
Authors:
Open Access
- 5 December 2022
- journal article
- research article
- Published by Elsevier in Hematology, Transfusion and Cell Therapy
- Vol. 46 (1) , 8-13
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Overall survival of Brazilian acute myeloid leukemia patients according to the European LeukemiaNet prognostic scoring system: a cross-sectional studyMedical Oncology, 2018
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panelBlood, 2017
- Improved outcome in acute myeloid leukemia patients enrolled in clinical trials: A national population-based cohort study of Danish intensive chemotherapy patientsOncotarget, 2016
- Acute myeloid leukemia: update in diagnosis and treatment in BrazilEinstein (São Paulo), 2011
- Molecular and cytogenetic abnormalities in acute myeloid leukemia: review and case studiesEinstein (São Paulo), 2011
- Impact of new prognostic markers in treatment decisions in acute myeloid leukemiaCurrent Opinion in Hematology, 2009
- Independent prognostic factors for AML outcomeHematology-American Society Hematology Education Program, 2009
- Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA resultsBlood, 2008
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- The CAGE Questionnaire: Validation of a New Alcoholism Screening InstrumentAmerican Journal of Psychiatry, 1974